Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for HIMS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 84.54M
March 31, 2026 -15.45M
December 31, 2025 -83.68M
September 30, 2025 -887.40M
June 30, 2025 -21.09M
March 31, 2025 -32.80M
December 31, 2024 -17.21M
September 30, 2024 -10.41M
June 30, 2024 -4.47M
March 31, 2024 13.04M
December 31, 2023 20.70M
September 30, 2023 -31.06M
June 30, 2023 2.373M
March 31, 2023 -4.113M
Date Value
December 31, 2022 6.003M
September 30, 2022 -2.576M
June 30, 2022 12.82M
March 31, 2022 18.45M
December 31, 2021 10.24M
September 30, 2021 -25.92M
June 30, 2021 22.74M
March 31, 2021 -163.32M
December 31, 2020 -8.082M
September 30, 2020 -24.75M
June 30, 2020 -14.10M
March 31, 2020 7.233M
December 31, 2019 0.00
September 30, 2019 -201.25M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
HealthEquity, Inc. -25.92M
Claritev Corp. -38.08M
CVS Health Corp. -1.884B
Eli Lilly & Co. -15.40B
Ontrak, Inc. --